Baird Financial Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
FAM
CIP
FLAM
CS
Baird Financial Group's ATRC Position: Q3 2022 in Review
Baird Financial Group sold out of AtriCure (ATRC) in Q3 2022, closing a stake of 5,823 shares — an estimated $238K sold.
Baird Financial Group first reported a position in ATRC in Q3 2021 and held it in 4 quarters. The position peaked at $379K in Q1 2022. 214 funds tracked by Wall St. Rank hold ATRC as of Q3 2022.
- Baird Financial Group reported no remaining AtriCure position as of Q3 2022 after selling out during the quarter.
- Baird Financial Group sold 5,823 AtriCure shares in Q3 2022, an estimated $238K.
- Baird Financial Group first reported a position in AtriCure in Q3 2021 and held it in 4 quarters.
- Baird Financial Group's AtriCure position peaked at $379K in Q1 2022.
- 214 funds tracked by Wall St. Rank held AtriCure as of Q3 2022.
Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.